If you purchased
MEI Pharma, Inc. securities and would like to join the action, please click "Join This Action" below.
We would handle the action on a contingent fee basis, whereby you would not be responsible for payment of our legal fees or expenses in the action.
MEIP STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF MEI PHARMA, INC. IS FAIR TO SHAREHOLDERS
February 23, 2023.
New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of MEI Pharma, Inc. (NASDAQ: MEIP) and Infinity Pharmaceuticals, Inc. is fair to MEI shareholders.
Per the merger agreement, pre-merger MEI shareholders are expected to own approximately 58.0% and pre-merger Infinity shareholders are expected to own approximately 42.0% of the outstanding equity of the combined company immediately following the merger. The investigation concerns whether MEI and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for MEI shareholders; and (2) disclose all material information necessary for MEI shareholders to adequately assess and value the merger consideration.
On behalf of MEI shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.